Skip to main content
Erschienen in:

28.11.2022 | case report

Onychomadesis in a COVID-19 patient

verfasst von: Zlatina Georgieva Ivanova, Teodor Ivanov Aleksiev, Hristo Petrov Dobrev, MD, PhD, DMSc

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 11-12/2023

Einloggen, um Zugang zu erhalten

Summary

We report the case of a 67-year-old woman who developed onychomadesis on 9 of her fingers 2 months after recovering from COVID-19, with subsequent full nail regrowth after 4 months. The development of onychomadesis in COVID-19 is probably related to inhibition of nail proliferation due to fever, direct viral damage, or an inflammatory process associated with endothelial damage and obliterative microangiopathy in the nail matrix area. Clinicians should be aware of nail changes and actively seek them out in patients with COVID-19.
Literatur
2.
Zurück zum Zitat Neri I, Guglielmo A, Virdi A, et al. The red half-moon nail sign: a novel manifestation of coronavirus infection. J Eur Acad Dermatol Venereol. 2020;34(11):e663–e5.CrossRefPubMedPubMedCentral Neri I, Guglielmo A, Virdi A, et al. The red half-moon nail sign: a novel manifestation of coronavirus infection. J Eur Acad Dermatol Venereol. 2020;34(11):e663–e5.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Unal E, Çakmak S, Yorulmaz A. The red half-moon nail sign in a COVID-19 patient. Our Dermatol Online. 2022;13(2):223–4.CrossRef Unal E, Çakmak S, Yorulmaz A. The red half-moon nail sign in a COVID-19 patient. Our Dermatol Online. 2022;13(2):223–4.CrossRef
4.
Zurück zum Zitat Natalello G, De Luca G, Gigante L, et al. Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. Microvasc Res. 2021;133:104071.CrossRefPubMed Natalello G, De Luca G, Gigante L, et al. Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. Microvasc Res. 2021;133:104071.CrossRefPubMed
6.
7.
Zurück zum Zitat Fernandez-Nieto D, Jimenez-Cauhe J, Ortega-Quijano D, et al. Transverse leukonychia (Mees’ lines) nail alterations in a COVID-19 patient. Dermatol Ther. 2020;33(6):e13863.CrossRefPubMedPubMedCentral Fernandez-Nieto D, Jimenez-Cauhe J, Ortega-Quijano D, et al. Transverse leukonychia (Mees’ lines) nail alterations in a COVID-19 patient. Dermatol Ther. 2020;33(6):e13863.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Tammaro A, Adebanjo G, Erasmus H‑P, Chello C, et al. Transverse orange nail lesions following SARS-CoV‑2 infection. Dermatol Ther. 2021;34(1):e14688.CrossRefPubMed Tammaro A, Adebanjo G, Erasmus H‑P, Chello C, et al. Transverse orange nail lesions following SARS-CoV‑2 infection. Dermatol Ther. 2021;34(1):e14688.CrossRefPubMed
9.
Zurück zum Zitat Ceccarelli M, Nakamura R, Canella C. Multiple retronychia following COVID-19 infection. J Emerg Med. 2021;24:101087. Ceccarelli M, Nakamura R, Canella C. Multiple retronychia following COVID-19 infection. J Emerg Med. 2021;24:101087.
10.
Zurück zum Zitat Demir B, Yuksel E, Cicek D, Turkoglu S. Heterogeneous red-white discoloration of the nail bed and distal onycholysis in a patient with COVID-19. J Eur Acad Dermatol Venereol. 2021;35(9):e551–e3.CrossRefPubMedPubMedCentral Demir B, Yuksel E, Cicek D, Turkoglu S. Heterogeneous red-white discoloration of the nail bed and distal onycholysis in a patient with COVID-19. J Eur Acad Dermatol Venereol. 2021;35(9):e551–e3.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Gulseren D, Yalıcı-Armagan B. Yellow-white fluorescence on the nails: A novel finding of Favipiravir used for the treatment of COVID-19. J Cosmet Dermatol. 2021;20(8):2392–3.CrossRefPubMedPubMedCentral Gulseren D, Yalıcı-Armagan B. Yellow-white fluorescence on the nails: A novel finding of Favipiravir used for the treatment of COVID-19. J Cosmet Dermatol. 2021;20(8):2392–3.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Kayıran M, Cebeci F, Erdemir V, et al. Fluorescence of nails and hair on Wood’s lamp examination in Covid pandemic; undefined effect of Favipiravir in humans. Dermatol Ther. 2021;34(1):e14740. Kayıran M, Cebeci F, Erdemir V, et al. Fluorescence of nails and hair on Wood’s lamp examination in Covid pandemic; undefined effect of Favipiravir in humans. Dermatol Ther. 2021;34(1):e14740.
13.
Zurück zum Zitat Kutlu O, Yılmaz S. Fingernail lunula luminescence in COVID-19 patients: Is it a favipiravir-related reaction or a novel manifestation of coronavirus infection. Photodermatol Photoimmunol Photomed. 2021;37(4):343–4.CrossRefPubMedPubMedCentral Kutlu O, Yılmaz S. Fingernail lunula luminescence in COVID-19 patients: Is it a favipiravir-related reaction or a novel manifestation of coronavirus infection. Photodermatol Photoimmunol Photomed. 2021;37(4):343–4.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Grover C, Saha S, Pandhi D. Nail changes in COVID-19: a cross sectional study from India. Indian Dermatol Online J. 2022;13:326–33.CrossRefPubMedPubMedCentral Grover C, Saha S, Pandhi D. Nail changes in COVID-19: a cross sectional study from India. Indian Dermatol Online J. 2022;13:326–33.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Wollina U, Kanitakis J, Baran R. Nails and COVID-19—A comprehensive review of clinical findings and treatment. Dermatol Ther. 2021;34(5):e15100.CrossRefPubMedPubMedCentral Wollina U, Kanitakis J, Baran R. Nails and COVID-19—A comprehensive review of clinical findings and treatment. Dermatol Ther. 2021;34(5):e15100.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Hardin J, Haber R. Onychomadesis: literature review. Br J Dermatol. 2015;172(3):592–6.CrossRefPubMed Hardin J, Haber R. Onychomadesis: literature review. Br J Dermatol. 2015;172(3):592–6.CrossRefPubMed
18.
Zurück zum Zitat Liu J, Veenstra J. COVID-19 associated onychomadesis. SKIN. 2021;5(3):286–8.CrossRef Liu J, Veenstra J. COVID-19 associated onychomadesis. SKIN. 2021;5(3):286–8.CrossRef
Metadaten
Titel
Onychomadesis in a COVID-19 patient
verfasst von
Zlatina Georgieva Ivanova
Teodor Ivanov Aleksiev
Hristo Petrov Dobrev, MD, PhD, DMSc
Publikationsdatum
28.11.2022
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 11-12/2023
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-022-00988-1

Weitere Artikel der Ausgabe 11-12/2023

Wiener Medizinische Wochenschrift 11-12/2023 Zur Ausgabe